AI-bio immuno-oncology

Building thenext generation ofcancer immunotherapies.

Nucleovir is developing AI-designed, biologically validated cancer immunotherapies.

Our platform links computational design with disciplined experimental validation, creating a focused pipeline of candidates selected for clinical relevance before trial-enabling development.

01 AI-native discovery

Proprietary computational workflows identify and prioritize tractable tumor-immune opportunities.

02 Biological validation

Candidate decisions are grounded in wet-lab and in vivo evidence before capital-intensive development.

03 Clinical-readiness gates

Programs are shaped around biomarkers, patient selection, and a credible clinical path from the outset.

Platform

An AI-bio platform built to turn tumor-immune insight into investable therapeutic programs.

Nucleovir combines AI-driven design, biological validation, and translational strategy to build a focused cancer immunotherapy pipeline while keeping internal models, assays, and targets confidential.

AI Candidate Engine

Computational workflows generate and rank therapeutic hypotheses against tumor-immune biology, manufacturability, and development constraints.

Validation Loop

Experimental biology pressure-tests candidate logic so resources concentrate on programs with stronger mechanistic and translational evidence.

Clinical Strategy

Clinical trial design, biomarker logic, patient selection, and partnerability are considered before candidates advance toward development.

Stealth programs

Focused oncology programs advancing through validation.

Pipeline details remain confidential.

Target biology, indication strategy, validation systems, and development plans are shared only through confidential investor, partner, and diligence discussions.

Partnerships

Open to focused collaborations with scientific, strategic, and capital partners.

We are selectively exploring partnerships across discovery, biological validation, platform expansion, translational development, and investor diligence. Detailed program information is shared only through confidential discussions.

Discovery partnerships

Scientific collaborations around high-conviction tumor-immune biology, modality fit, and tractable therapeutic opportunities.

Validation partnerships

Collaborations that pressure-test internal hypotheses through rigorous biological and translational evidence.

Strategic and investor conversations

Confidential discussions with organizations and investors aligned with next-generation immunotherapy development.

Founders

Yogesh Ostwal, PhD

Co-Founder, CEO

Ayush Ranawade, PhD

Co-Founder, CSO

Sunil Kapgate, PhD

Co-Founder, CTO

Careers

PhD-level roles for scientists who learn as fast as Bio-AI evolves.

Nucleovir is looking for talented, self-directed lifelong learners who can keep pace with the speed of AI-biology. These are PhD-level positions for people who combine deep scientific training, rigorous execution, and the humility to keep learning. Recent PhD graduates and postdocs are strongly encouraged to apply; industry experience is optional.

Opening

Computational Biology / Bioinformatics Scientist

For PhD-level scientists who can turn multi-modal oncology, immunology, and molecular datasets into AI-ready training data, therapeutic hypotheses, and program decisions.

Details

Eligibility

PhD in computational biology, bioinformatics, systems biology, statistics, computer science, immunology, cancer biology, or a related field.
Recent PhD graduates and postdocs are strongly encouraged to apply; industry experience is optional.
Strong lifelong-learning mindset and ability to rapidly absorb new methods in AI, single-cell biology, immunology, and translational oncology.
Hands-on experience with Python and/or R, statistical analysis, reproducible workflows, biological data interpretation, and training dataset curation.

Opening

Data Scientist / Machine Learning Engineer

For PhD-level quantitative scientists who can build reliable AI systems and large-scale training datasets for biological discovery.

Details

Eligibility

PhD in machine learning, computer science, statistics, computational biology, bioengineering, physics, applied mathematics, or a related quantitative field.
Recent PhD graduates and postdocs are strongly encouraged to apply; industry experience is optional.
Strong foundations in statistical learning, model evaluation, data engineering, dataset design, and reproducible software development.
Curiosity to learn biological context quickly and apply quantitative judgment to therapeutic discovery.

Opening

Immunology / Virology / Translational Scientist

For PhD-level scientists who can connect tumor immunology, mechanism, biomarker logic, and clinical translation.

Details

Eligibility

PhD in immunology, virology, oncology, cancer biology, translational science, or a related biological discipline.
Recent PhD graduates and postdocs are strongly encouraged to apply; industry experience is optional.
Deep interest in tumor-immune biology and the discipline to keep learning as immunotherapy and AI-biology advance.
Ability to reason from mechanism to assay strategy, biomarkers, patient selection, and development risk.

Opening

AI Scientist / Engineer, Hybrid Multimodal LLMs

For PhD-level AI scientists and engineers who can build hybrid LLM architectures for complex multimodal biological reasoning tasks.

Details

Eligibility

PhD in machine learning, computer science, computational biology, bioengineering, applied mathematics, statistics, or a related AI/quantitative field.
Recent PhD graduates and postdocs are strongly encouraged to apply; industry experience is optional.
Strong understanding of LLMs, multimodal learning, retrieval systems, tool-using agents, model evaluation, and scalable AI system design.
Ability to learn fast across biology and AI, and to translate rapidly evolving LLM research into robust internal platform architecture.

Get in touch

Reach out for careers, partnerships, or investor conversations.

Tell us whether you are interested in joining the team, exploring a partnership, or starting a confidential conversation with Nucleovir.

info@nucleovir.com AIC, IISER, G1 Block, Pune, Maharashtra 411008, India